Ayer Capital Management

Ayer Capital Management as of Sept. 30, 2012

Portfolio Holdings for Ayer Capital Management

Ayer Capital Management holds 31 positions in its portfolio as reported in the September 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Teva Pharmaceutical Industries (TEVA) 10.2 $24M 581k 41.41
Grifols S A 7.7 $18M 794k 22.83
ArthroCare Corporation 7.5 $18M 548k 32.40
Celgene Corporation 6.6 $16M 204k 76.40
Ariad Pharmaceuticals 6.4 $15M 623k 24.23
Insmed (INSM) 6.0 $14M 3.1M 4.55
Endologix 5.8 $14M 1.0M 13.82
NPS Pharmaceuticals 5.7 $13M 1.5M 9.25
Oncothyreon 4.8 $11M 2.2M 5.14
Dynavax Technologies Corporation 4.5 $11M 2.2M 4.76
McKesson Corporation (MCK) 3.6 $8.4M 98k 86.03
CIGNA Corporation 3.5 $8.4M 177k 47.17
Cardinal Health (CAH) 2.9 $6.8M 174k 38.97
Threshold Pharmaceuticals 2.6 $6.2M 855k 7.24
Sunesis Pharmaceuticals 2.6 $6.1M 1.1M 5.65
Dendreon Corp cnv 2.5 $5.9M 6.2M 0.96
Hologic (HOLX) 2.2 $5.1M 253k 20.24
Chemocentryx 2.1 $5.1M 435k 11.63
ZIOPHARM Oncology 1.9 $4.4M 809k 5.45
Ym Biosciences 1.6 $3.7M 2.0M 1.84
ShangPharma 1.4 $3.2M 426k 7.62
Universal Health Services (UHS) 1.3 $3.1M 68k 45.74
BioSpecifics Technologies 1.2 $2.8M 142k 19.42
Neptune Technologies Bioreso 1.1 $2.6M 650k 3.95
Biolinerx Ltd-spons 1.1 $2.5M 957k 2.63
Celgene Corp right 12/31/2011 1.0 $2.5M 871k 2.83
Omeros Corporation (OMER) 0.9 $2.1M 225k 9.40
Peregrine Pharmaceuticals Inc. cmn 0.9 $2.1M 2.0M 1.03
Cyclacel Pharmaceuticals 0.3 $823k 221k 3.73
Palatin Technologies 0.3 $763k 1.1M 0.67
Cytokinetics 0.2 $415k 500k 0.83